Bain Capital-backed Heartflow set to open higher in Nasdaq debut
** Bain Capital-backed medical technology firm Heartflow's HTFL.O shares indicated to open above offer price in Nasdaq debut
** Stock indicated to open at $25 vs $19 IPO price
** HTFL late Thursday sold 16.7 million shares above the marketed range of $17 and $18 apiece for gross proceeds of $316.7 million in an upsized IPO
** Mountain View, California-based HTFL upsized its offering and raised the proposed range earlier this week reflecting strong demand
** HTFL marks the third sizable medtech listing in New York in less than a month
** Founded in 2007 as Cardiovascular Simulation, Heartflow's AI-enabled products help physicians to diagnose and treat heart disease
** J.P. Morgan, Morgan Stanley and Piper Sandler were the lead underwriters for the offering
Related Articles
Investing in Artificial General Intelligence (AGI)
AGI promises transformative productivity and economic gains but carries unprecedented technical, ethical, and social risks.Significant exposure comes through tech giants, semiconductor leaders, and cloud infrastructure providers, fueling AGI research.
Investing in Edge Computing
Edge computing complements the cloud by reducing latency, saving bandwidth, and enhancing privacy for real-time applications. Growth is fueled by IoT expansion, 5G rollout, AI integration, and enterprise digital transformation.
What Is Worldcoin? Why Did WLD Surge Suddenly, and What’s Next?
Worldcoin is evolving from a “hype token” into a foundational layer for global identity. Its fusion of biometrics, blockchain, and financial inclusion has earned growing recognition from users and institutions. If it can overcome technical hurdles, launch real-world payment use cases, and stabilize
U.S. Stock Sector Strategy: The Outlook for Tech Stocks from a Macro Perspective
TradingKey - Against the backdrop of easing trade war tensions, sustained economic resilience, and the Federal Reserve's anticipated interest rate cuts, the U.S. stock market is expected to maintain its upward trajectory. At the sector level, we are optimistic about U.S. technology stocks...
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.
